<![CDATA[EPoS Study

<![CDATA[EPoS Study - News]]>Fri, 04 Oct 2024 15:23:15 -0700Weebly<![CDATA[October 1st]]>Tue, 01 Oct 2024 20:30:03 GMThttps://www.eposstudy.org/updates/october-1stAnnouncement

We are pleased to announce that the inclusion phase for EPOS IV is now officially closed. We extend our heartfelt thanks to all our partners for their dedication and invaluable efforts throughout this process.

We are thrilled to share that the preliminary results of the EPOS IV study were presented at ESGE Days in Berlin!

You can view the abstract here: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0044-1783272

]]><![CDATA[Update April 01, 2023]]>Sat, 01 Apr 2023 07:00:00 GMThttps://www.eposstudy.org/updates/update-april-01-2023Our recruitment reached 167 patients! Congratulations to all participating centers!]]><![CDATA[Update December 12, 2022]]>Mon, 12 Dec 2022 08:00:00 GMThttps://www.eposstudy.org/updates/update-december-12-2022Two more sites has joined our trial! Akershus University Hospital from Norway and Ospedale dei Castelli Hospital, Ariccia, Rome, Italy. Welcome!]]><![CDATA[Recrutation for the EPOS IV is opened]]>Tue, 01 Nov 2022 16:55:31 GMThttps://www.eposstudy.org/updates/recrutation-for-the-epos-iv-is-openedWe encourage to join the study.

If your centre manages patients after treatment of pT1 colorectal cancer, please contact as at: nastazja.pilonis@coi.pl

]]><![CDATA[SURVEILLANCE STATUS]]>Tue, 19 Jul 2022 15:37:19 GMThttps://www.eposstudy.org/updates/surveillance-status

]]>